4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001415889-24-028928
CEO sold 6,786 shares at $12.99 ($88,158)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kaye Edward M. MD CEO | 2024-12-09 | Sale | −6,786 | $12.99 | $88,158 | 61,885 | D |
| Open-market sales · 6,786 sh · avg $12.99 · $88,158 | |||||||
Loading xslF345X05/form4-12112024_091247.xml…